Health & Medicine

The largest philanthropic gift to kinesiology in Canadian university history supports a long-term vision for global healthspan research, education, health policy and community impact.

Insights from the study of protein alpha-synuclein could lead to earlier detection of the neurogenerative disease.

Manikomycin, which blocks the exit site of the protein-producing machinery in bacteria, is the fourth major discovery from antimicrobial resistance expert Gerry Wright’s research team in recent months.

The study finds only moderate consistency in the results of standardized diagnostic interviews for adult mental and substance use disorders.

The students are participating in a multiweek pitching experience that is part of the Harvard Health Systems Innovation Lab Hackathon.

The F.N.G. Starr award recognizes Loeb's decades of leadership in infectious disease research, landmark clinical trials and public health advocacy that shaped medical practice and policy in Canada and around the world.

An increase in the number of kindergarten children with special needs since the pandemic means more children will require specialized assistance and accommodation in later grades.

A new study from McMaster researchers helps explain, at the molecular level, how what we eat can impact frailty as we age.

The John G. FitzGerald Award recognizes Smieja for advancing the diagnosis and epidemiology of respiratory and gastrointestinal infections, including those caused by SARS-CoV-2, influenza, rhinovirus, and C. difficile.

New research suggests that fine particles from traffic, industry and wildfire smoke are linked to worse cognitive function.

The drug candidate can eliminate deadly and aggressive glioblastoma tumours, which typically resist standard treatments and often recur rapidly.

New “organ-on-a-chip” technology offers alternative to animal studies.